Composition
- Active ingredients
- CLEMASTINE FUMARATE EQ 0.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLEMASTINE FUMARATE 2.68MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017661-001 · Discontinued
- CLEMASTINE FUMARATE EQ 0.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SyrupThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA018675.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tavist
- Active substance
- clemastine fumarate
- Route
- Oral
- Dosage form
- Syrup
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 28 Jun 1985
- Application
- NDA018675-001